Whole slide

PITTSBURGH, PA, September 12, 2018 – SpIntellx, Inc., a computational pathology company, today announced the recent closing of a seed financing round led by Newlin Investment Company, an early-stage venture capital firm. Spintellx is applying...

Visiopharm Phenomap software presented at the Fluidigm Imaging Mass Cytometry User Group Meeting, expanding the suite of Hyperion Imaging System data analysis tools for translational and clinical research Fluidigm Corporation (NASDAQ:FLDM)...

San Jose, CA, September 12th, 2018: OptraSCAN®, the leading end-to-end digital pathology solution provider today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to “In-Vitro...

Introducing Visiopharm PhenomapTM Multiplexing a novel software tool to help you streamline and automate the analysis workflow of high dimensional multiplex datasets, for deeper understanding of potential relationships in the tumor...

Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be as effective as manual pathology. The study, “Validation of a Muscle-Specific Tissue...

Stop by booth B1 at the Euskalduna Conference Centre for a hands-on experience using the next-generation of the popular Omnyx Dynamyx digital pathology software. Inspirata, Inc. - September 06, 2018 01:00 ET Bilbao, Spain, Sept. 06, 2018...